Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia

Clinical trial NCT05302271 · RECRUITING

Trial details

NCT number: NCT05302271
Sponsor: Weill Medical College of Cornell University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Friedreich Ataxia Cardiomyopathies Cardiac Hypertrophy Myocardial Fibrosis

Start date: 2022-02-22
Primary completion: 2028-12-31
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.